FDA Updates for the Week of June 6, 2022

FDA Updates for the Week of June 6, 2022

In COVID-19 news, an FDA advisory committee recommends EUA for Novavax’s vaccine. The FDA has also granted approvals to Dupixent for children as young as 6 month with atopic dermatitis and to the biosimilar Riabni for rheumatoid arthritis. An advisory committee has also recommended approval for two gene therapies, one for a rare neurogenerative disease …

FDA Updates for the Week of June 6, 2022 Read More »